Roy Guharoy
About
In The Last Decade
Roy Guharoy
31 papers receiving 351 citations
Peers
Comparison fields: 5 of 94
- Geriatrics and Gerontology 95
- Infectious Diseases 79
- Pharmacology 55
- Emergency Medical Services 55
- Pediatrics, Perinatology and Child Health 54
Countries citing papers authored by Roy Guharoy
This map shows the geographic impact of Roy Guharoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Guharoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Guharoy more than expected).
Fields of papers citing papers by Roy Guharoy
This network shows the impact of papers produced by Roy Guharoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Guharoy. The network helps show where Roy Guharoy may publish in the future.
Co-authorship network of co-authors of Roy Guharoy
This figure shows the co-authorship network connecting the top 25 collaborators of Roy Guharoy. A scholar is included among the top collaborators of Roy Guharoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy Guharoy. Roy Guharoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 6 | |
| 6 | 24 | |
| 7 | 1 | |
| 8 | 14 | |
| 9 | 5 | |
| 10 | 30 | |
| 11 | 1 | |
| 12 | 23 | |
| 13 | 8 | |
| 14 | 13 | |
| 15 | 20 | |
| 16 | 10 | |
| 17 | 63 | |
| 18 | Lymphadenopathy secondary to lamotrigine (Lamictal). | 3 |
| 19 | Methamphetamine overdose: experience with six cases. | 5 |
| 20 | Fatal adverse event secondary to high osmolality contrast agent. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.